Moderna 20 avr. 2026 Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNEXSPIKE - Fierce Pharma
Moderna 20 avr. 2026 Is It Too Late To Consider Moderna (MRNA) After A 114% One Year Surge? - simplywall.st
Moderna 19 avr. 2026 Moderna’s mRNA Melanoma Data And Fast Track Status Shape Oncology Story - Yahoo Finance
Moderna 17 avr. 2026 Updated: Kailera's shares climb after overtaking Moderna's IPO record with $625M raise - FirstWord Pharma
10x Genomics Blog 27 mars 2026 Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know - Yahoo Finance
Endpoints News 3 mars 2026 Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant
BioPharma Dive 27 févr. 2026 Moderna’s combination flu, COVID shot wins over European drug regulators
Endpoints News 21 févr. 2026 Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more